( As on 15/05/2025 14:14)
Lupin Limited has informed the Exchange regarding a press release dated May 15, 2025, titled ""Lupin Receives Approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg"".